Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Mesenchymal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00112645
What this trial is testing

Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
NeuroblastomaSarcomaUnspecified Childhood Solid Tumor, Protocol Specific
Milton S. Hershey Medical Center 10
Not applicableLooking for participantsNCT06349642
What this trial is testing

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Who this might be right for
Early Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more
Mayo Clinic 324
Early research (Phase 1)Ended earlyNCT04627142
What this trial is testing

Test Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutation

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Boehringer Ingelheim 15
Testing effectiveness (Phase 2)Ended earlyNCT05496569
What this trial is testing

TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma

Who this might be right for
Dedifferentiated Liposarcoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 26
Not applicableNo Longer AvailableNCT04225429
What this trial is testing

Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma

Who this might be right for
Epithelioid Sarcoma
Epizyme, Inc.
Testing effectiveness (Phase 2)Study completedNCT00006251
What this trial is testing

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer

Who this might be right for
Acute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more
Fred Hutchinson Cancer Center 21
Large-scale testing (Phase 3)Study completedNCT00834457
What this trial is testing

A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe

Who this might be right for
AIDS-related Kaposi's Sarcoma
Parirenyatwa Hospital 49
Testing effectiveness (Phase 2)Study completedNCT00288015
What this trial is testing

Bevacizumab in Treating Patients With Angiosarcoma

Who this might be right for
Sarcoma
Northwestern University 32
Not applicableStudy completedNCT01807143
What this trial is testing

Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma

Who this might be right for
Osteosarcoma
Children's Oncology Group 10
Testing effectiveness (Phase 2)Study completedNCT01206140
What this trial is testing

Selumetinib With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery

Who this might be right for
Recurrent Adult Soft Tissue SarcomaStage III Adult Soft Tissue SarcomaStage IV Adult Soft Tissue Sarcoma
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Study completedNCT00087997
What this trial is testing

STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas

Who this might be right for
Soft Tissue Sarcoma
Synta Pharmaceuticals Corp. 80
Not applicableStudy completedNCT06216990
What this trial is testing

Metastatic or Refractory Soft Tissue Sarcomas and Metronomic Cyclophosphamide: Further Assessment of Efficacy and Safety

Who this might be right for
SarcomaSoft Tissue Sarcoma
Centre Hospitalier Universitaire de Besancon 60
Testing effectiveness (Phase 2)Ended earlyNCT02718482
What this trial is testing

Phase II Trial for the Treatment of Relapsed Osteosarcoma

Who this might be right for
OSTEOSARCOMA
Italian Sarcoma Group 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT00496522
What this trial is testing

Proton Beam Therapy for Chondrosarcoma

Who this might be right for
Chondrosarcoma
M.D. Anderson Cancer Center 15
Not applicableLooking for participantsNCT05944913
What this trial is testing

Study Comparing Negative Pressure Dressing vs Conventional in Patients With Resected STS After Radiotherapy

Who this might be right for
Soft Tissue Sarcoma
Centre Leon Berard 166
Very early researchNot Yet RecruitingNCT06887673
What this trial is testing

Lipid Mediators & Cancer: Montelukast, SPM, and Almonds

Who this might be right for
Colorectal CancerSarcomaBrain Tumors+2 more
University of South Florida 56
Large-scale testing (Phase 3)Study completedNCT01440088
What this trial is testing

A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Threshold Pharmaceuticals 640
Testing effectiveness (Phase 2)Study completedNCT00189137
What this trial is testing

Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
University of Michigan Rogel Cancer Center 84
Testing effectiveness (Phase 2)Study completedNCT03725605
What this trial is testing

LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04)

Who this might be right for
Soft Tissue Sarcoma
Lytix Biopharma AS 6
Early research (Phase 1)Study completedNCT00927966
What this trial is testing

RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms

Who this might be right for
SarcomaSolid Tumor
Suzanne George, MD 21
Next Page